NCT04377399View on ClinicalTrials.gov

High vs Low Dose Vitamin D in Patients With Diabetic Peripheral Neuropathy

PHASE4CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

January 10, 2018

Primary Completion Date

June 20, 2019

Study Completion Date

January 25, 2020

Conditions
Diabetes Type 2Diabetic NeuropathiesVitamin D Deficiency
Interventions
DRUG

Vitamin D

Patients will be randomised to receive either high dose vitamin D (40,000 IU weekly) or low dose vitamin D (5,000 IU weekly) for 24 weeks

Trial Locations (1)

197143

Almazov National Medical Research Centre, Saint Petersburg

All Listed Sponsors
collaborator

Tameside Hospital NHS Foundation Trust

OTHER

lead

Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health

OTHER

NCT04377399 - High vs Low Dose Vitamin D in Patients With Diabetic Peripheral Neuropathy | Biotech Hunter | Biotech Hunter